Report #2857758

Received Sep 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: Aug 22, 2025
Onset: Aug 22, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (1)

Expired product administered

Symptom narrative

administered a dose of Arexvy on Aug 22, 2025, that had expired July 2025; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of expired vaccine used in a female patient who received RSVPreF3 adjuvanted (Arexvy) (expiry date 31-JUL-2025) for prophylaxis. On 22-AUG-2025, the patient received the 1st dose of Arexvy (unknown deltoid). On 22-AUG-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: administered a dose of Arexvy on Aug 22, 2025, that had expired July 2025). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 22-Aug-2025 No patient details provided by reporter.